Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8485 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8204 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8092 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.807 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8024 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7989 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7929 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7853 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7849 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7841 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD919 |
Approved |
0.7802 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD1512 |
Approved |
0.767 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7654 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7654 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7611 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7554 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD920 |
Approved |
0.7529 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7529 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7472 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7472 |
Intermediate Similarity |
NPD5711 |
Approved |
0.747 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7446 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7446 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7442 |
Intermediate Similarity |
NPD3226 |
Approved |
0.743 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7396 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7382 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7296 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7249 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7202 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7121 |
Intermediate Similarity |
NPD8319 |
Approved |
0.712 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7098 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7098 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD37 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD6764 |
Approved |
0.6968 |
Remote Similarity |
NPD6765 |
Approved |
0.6946 |
Remote Similarity |
NPD943 |
Approved |
0.6938 |
Remote Similarity |
NPD8366 |
Approved |
0.6935 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD3268 |
Approved |
0.6919 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6882 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6881 |
Remote Similarity |
NPD7584 |
Approved |
0.6879 |
Remote Similarity |
NPD7003 |
Approved |
0.6878 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6867 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6857 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6845 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6842 |
Remote Similarity |
NPD5406 |
Approved |
0.6842 |
Remote Similarity |
NPD5404 |
Approved |
0.6842 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6842 |
Remote Similarity |
NPD5408 |
Approved |
0.6842 |
Remote Similarity |
NPD5405 |
Approved |
0.6842 |
Remote Similarity |
NPD4665 |
Approved |
0.6826 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD3764 |
Approved |
0.6823 |
Remote Similarity |
NPD6784 |
Approved |
0.6823 |
Remote Similarity |
NPD6785 |
Approved |
0.6808 |
Remote Similarity |
NPD8491 |
Approved |
0.68 |
Remote Similarity |
NPD2493 |
Approved |
0.68 |
Remote Similarity |
NPD2494 |
Approved |
0.6796 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.679 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6789 |
Remote Similarity |
NPD7240 |
Approved |
0.6788 |
Remote Similarity |
NPD2798 |
Approved |
0.6784 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6782 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6782 |
Remote Similarity |
NPD4582 |
Approved |
0.6782 |
Remote Similarity |
NPD4583 |
Approved |
0.678 |
Remote Similarity |
NPD6273 |
Approved |
0.6778 |
Remote Similarity |
NPD5890 |
Approved |
0.6778 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6778
|
Remote Similarity |
NPD5889 |
Approved |